原发性脑性淋巴瘤和自身免疫性肝炎:一种与长期治疗mycophenolate mofetil相关的不寻常病例
María Aragüés Floristán1, Marta Obra Pinacho2, Adolfo Jesús Sáez Marín3
1Aparato Digestivo, Hospital Universitario 12 de Octubre, Spain.
Revista espanola de enfermedades digestivas
|April 8, 2025
概括
针对自身免疫性肝炎 (AIH) 的长期免疫抑制可以增加癌症风险. 本案例研究显示,一个患者在治疗mycophenolate mofetil期间发展出原发性脑淋巴瘤,并通过rituximab成功治疗.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
背景情况:
- 自身免疫性肝炎 (AIH) 管理通常涉及免疫抑制剂,如皮质类固醇,阿扎西奥普林或mycophenolate mofetil.
- 长期的免疫抑制疗法是二次恶性瘤的已知危险因素.
- 治疗AIH和瘤疾病发展之间的相互作用需要仔细考虑.
研究的目的:
- 报告一种罕见的原发性脑淋巴瘤病例,在慢性自身免疫性肝炎的治疗期间发生.
- 讨论如何管理这种同时出现的疾病.
- 评估利图西马布在管理AIH和相关淋巴瘤方面的潜在作用.
主要方法:
- 一名患有慢性自身免疫性肝炎 (AIH) 的患者接受了mycophenolate mofetil的治疗.
- 随后,该患者患上了原发性脑淋巴瘤.
- 治疗包括用于淋巴瘤的甲状腺激素和修复剂,并观察AIH管理.
主要成果:
- 对AIH的mycophenolate mofetil治疗与原发性脑淋巴瘤的发展有关.
- 患者的淋巴瘤被有效地用甲状腺和修复剂治疗.
- 利图西马布在治疗淋巴瘤和潜在地影响AIH的过程中表现出有效性.
结论:
- 在AIH中长期免疫抑制带来了二次癌症的风险,包括原发性脑淋巴瘤.
- 作为一种免疫调节剂的利图西马布可以成为淋巴瘤和潜在的AIH治疗的可行治疗选择.
- 这一案例凸显了在接受免疫抑制治疗的慢性AIH患者中对瘤并发症的警监测的重要性.
相关概念视频
01:20Myasthenia Gravis: Overview and Treatment
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
01:27Cryptococcal Meningitis
Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
01:19Encephalitis l: Introduction
Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...
01:29Hepatic Encephalopathy
DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...